Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genetic Tech Spn ADR (NQ: GENE )

0.7650 UNCHANGED
Last Price Updated: 3:59 PM EDT, Oct 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Genetic Tech Spn ADR

< Previous 1 2 Next >
BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType to Enter Canadian and New Zealand Markets
Genomics-based testing brand expands international presence as pilot influencer campaign fuels sales 
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Results from commercial sales of predictive testing across the US and Australia establish clear advantages of geneType Risk Assessment Tests for a more preventive approach in disease management 
From Genetic Technologies Ltd
Via GlobeNewswire
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Expands Operational Capacity in North America
Global leader in personalized predictive genetics launches testing operations for geneType disease risk assessments at US based, world-leading genetic laboratory, Gene by Gene 
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
From Genetic Technologies Ltd
Via GlobeNewswire
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType and Humanise Health host “Know Your Risk” Event
From Genetic Technologies Ltd
Via GlobeNewswire
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
From Genetic Technologies Ltd
Via GlobeNewswire
Appendix 4C & Quarterly Business Update – March 2024
Launching our most comprehensive test and expanding into new global markets 
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Announces $2 Million Registered Direct Offering
From Genetic Technologies Ltd
Via GlobeNewswire
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
GTG to pilot GeneType in Breast Screen centers across the U.S.
From Genetic Technologies Ltd
Via GlobeNewswire
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
From Genetic Technologies Ltd
Via GlobeNewswire
GTG Global Collaborations and Innovation Update
From Genetic Technologies Ltd
Via GlobeNewswire
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
From Genetic Technologies Ltd
Via GlobeNewswire
GTG to launch U.S. Customer Digital Media Sales Campaign
From Genetic Technologies Ltd
Via GlobeNewswire
Launching our most comprehensive test and expanding into new global markets
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
From Genetic Technologies Ltd
Via GlobeNewswire
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
From Genetic Technologies Ltd
Via GlobeNewswire
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
From Genetic Technologies Ltd
Via GlobeNewswire
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
From Genetic Technologies Ltd
Via GlobeNewswire
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS